Difficulty: Medium
Average Score: 76%
Practice
Which of the following clients is at greatest risk for extravasation?
Correct answer
B
Rationale
The correct answer is B) The client with cancer who is receiving bendamustine is at the greatest risk for extravasation. Extravasation occurs when a vesicant medication, like bendamustine, leaks into the surrounding tissue during intravenous administration, leading to tissue damage, necrosis, and potential long-term complications. This is because vesicant medications are highly irritating to the tissues.
Option A) The client with heart failure receiving Ringer's lactate is not at the greatest risk for extravasation. Ringer's lactate is not a vesicant medication, so the risk of tissue damage from extravasation is lower.
Option C) The client receiving potassium supplementation intravenously is also not at the greatest risk for extravasation. While potassium can be irritating to the veins if administered too quickly or in concentrated form, it is not a vesicant medication like bendamustine.
Option D) The client receiving total parenteral nutrition is not at the greatest risk for extravasation. Total parenteral nutrition, while crucial for providing essential nutrients, is not a vesicant medication and therefore does not pose the same risk of tissue damage if extravasated.
In an educational context, it is essential for nurses to be aware of the risks associated with different medications and intravenous therapies to provide safe and effective care to their patients. Understanding which medications are vesicants and the potential complications of extravasation is crucial for preventing harm to patients and ensuring optimal outcomes. Nurses should be vigilant in monitoring IV sites and promptly reporting any signs of extravasation to prevent further complications.
Option A) The client with heart failure receiving Ringer's lactate is not at the greatest risk for extravasation. Ringer's lactate is not a vesicant medication, so the risk of tissue damage from extravasation is lower.
Option C) The client receiving potassium supplementation intravenously is also not at the greatest risk for extravasation. While potassium can be irritating to the veins if administered too quickly or in concentrated form, it is not a vesicant medication like bendamustine.
Option D) The client receiving total parenteral nutrition is not at the greatest risk for extravasation. Total parenteral nutrition, while crucial for providing essential nutrients, is not a vesicant medication and therefore does not pose the same risk of tissue damage if extravasated.
In an educational context, it is essential for nurses to be aware of the risks associated with different medications and intravenous therapies to provide safe and effective care to their patients. Understanding which medications are vesicants and the potential complications of extravasation is crucial for preventing harm to patients and ensuring optimal outcomes. Nurses should be vigilant in monitoring IV sites and promptly reporting any signs of extravasation to prevent further complications.